Metraipolis › archive › dc_ae07a398bbb5

Emerging macrophage-based therapies for cancer: a review of preclinical and clinical advances — Europe PMC PMID:41112239

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41112239
DOI
10.3389/fimmu.2025.1679271
License (as archived)
solo-consultazione
Archived
2026-11-09T15:22:25.352Z
SHA-256 of the archived text
c49fbd8df81f3857cc159343172cc9315e4f53329b82099da88131974b79fed3
Stable URL of this page
https://metraipolis.com/documento/dc_ae07a398bbb5

How to cite

Emerging macrophage-based therapies for cancer: a review of preclinical and clinical advances — Europe PMC PMID:41112239 — Europe PMC (en), https://europepmc.org/article/MED/41112239 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ae07a398bbb5 (Metraipolis archive dc_ae07a398bbb5, sha256 c49fbd8df81f3857cc159343172cc9315e4f53329b82099da88131974b79fed3)
BibTeX
@misc{dcae07a398bbb5,
  title = {Emerging macrophage-based therapies for cancer: a review of preclinical and clinical advances — Europe PMC PMID:41112239},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41112239},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ae07a398bbb5; sha256 c49fbd8df81f3857cc159343172cc9315e4f53329b82099da88131974b79fed3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41112239. Agents can read the archived copy with the MCP tool read_document.